Back to Search
BRIAN SANFORD, PHARMD
PHARMD
Pharmacist
NPI: 1336037977Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
0202218790(VA)102862-40(WI)
Research & Publications (15)
A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102.
PMID 19168670·Ann Oncol·2009
3-trial
Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720.
PMID 18591543·J Clin Oncol·2008
3-trial
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.
PMID 18502832·Blood·2008
3-trial
p53 protein expression status and recurrence in men treated with radiation and androgen suppression therapy for higher-risk prostate cancer: a prospective phase II Cancer and Leukemia Group B Study (CALGB 9682).
PMID 18291508·Urology·2008
3-trial
Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207.
PMID 18272914·Ann Oncol·2008
3-trial
Tumor volume changes on 1.5 tesla endorectal MRI during neoadjuvant androgen suppression therapy for higher-risk prostate cancer and recurrence in men treated using radiation therapy results of the phase II CALGB 9682 study.
PMID 18037582·Int J Radiat Oncol Biol Phys·2008
3-trial
A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma: results of the Cancer and Leukaemia Group B 90102.
PMID 17922873·BJU Int·2008
3-trial
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511.
PMID 17264295·Blood·2007
3-trial
Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone- refractory prostate cancer: results from cancer and leukemia group B 150005/9480.
PMID 16729910·Clin Genitourin Cancer·2006
8-other
Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study.
PMID 16098367·Urology·2005
8-other
The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480.
PMID 15756004·Clin Cancer Res·2005
4-observational
Influence of near-ultraviolet radiation on reproductive and immunological development in juvenile male Siberian hamsters.
PMID 11511669·J Exp Biol·2001
7-preclinical
St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature.
PMID 11243487·Psychopharmacology (Berl)·2001
6-review
Human melatonin regulation is not mediated by the three cone photopic visual system.
PMID 11232036·J Clin Endocrinol Metab·2001
8-other
The effect of polarized versus nonpolarized light on melatonin regulation in humans.
PMID 10857374·Photochem Photobiol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1000 N OAK AVE STE 100
MARSHFIELD, WI 54449 - Phone
- (715) 387-5511
Quick Facts
- NPI
- 1336037977
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 15
Are you this provider?
Claim Your Profile